Compression stockings do not add clinical benefit to pharmaco-thromboprophylaxis
1. For patients who underwent elective surgery and were at moderate to high risk of venous thromboembolism, pharmaco-thromboprophylaxis with low ...
Tag: heparin
2 Minute Medicine Rewind May 18, 2020
Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: ...
#VisualAbstract: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation dysfunction: ...
COVID-19 patients with coagulation dysfunction may benefit from prophylactic anticoagulation
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation ...
Quick Take: Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer
Venous thromboembolism (VTE) is a common complication in patients with cancer. Often, VTEs are incidentally detected on imaging studies undertaken ...
Adverse outcomes are similar for patients undergoing percutaneous coronary intervention receiving heparin or bivalirudin
1. Patients undergoing percutaneous coronary intervention (PCI) mainly via radial approach receiving either bivalirudin or heparin, in addition to P2Y12 ...
2 Minute Medicine Rewind November 3 – November 9, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Cost-Effectiveness ...
2 Minute Medicine Rewind October 26 – November 2, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Clinical ...
Blood clot prophylaxis for medicine inpatients may be unnecessary
1. Patients who were admitted to the general medicine service for a short stay had a very low risk of developing a ...
Rivaroxaban has no net clinical benefit over enoxaparin for thromboprophylaxis in acutely ill patients
Feb 6th - NEJM - Extended-duration rivaroxaban was superior to standard-duration enoxaparin for thromboprophylaxis, but was associated with increased bleeding ...